Human atrial action potential and Ca 2+ model: Sinus rhythm and chronic atrial fibrillation

Circulation Research

Volumn 109, Issue 9, 2011, Pages 1055-1066

  Grandi, Eleonora ^a   Pandit, Sandeep V ^b   Voigt, Niels ^c   Workman, Antony J ^d   Dobrev, Dobromir ^c   Jalife, José ^b   Bers, Donald M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

action potential; atrial fibrillation; Ca 2+ cycling; computer model

Indexed keywords

CALCIUM ION; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM ION;

ACTION POTENTIAL; ARTICLE; CARDIAC CHANNELOPATHY; CHANNELOPATHY; CONTROLLED STUDY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SINUS RHYTHM;

ACTION POTENTIALS; ATRIAL FIBRILLATION; CALCIUM; CALCIUM CHANNELS, L-TYPE; CHRONIC DISEASE; HEART ATRIA; HEART VENTRICLES; HOMEOSTASIS; HUMANS; KV1.5 POTASSIUM CHANNEL; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC; SINOATRIAL NODE; SODIUM;

EID: 80055004672     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.253955     Document Type: Article

References (65)

1. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2009;119:606-618.
2. Jalife J. Deja vu in the theories of atrial fibrillation dynamics. Cardiovasc Res. 2011;89:766-775.
3. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation. Circ Arrhythm Electrophysiol. 2008;1:62-73.
4. Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol. 2003;98:137-148. (Pubitemid 36740668)
5. Workman AJ, Kane KA, Rankin AC. Cellular bases for human atrial fibrillation. Heart Rhythm. 2008;5(6 Suppl):S1-S6.
6. Dobrev D, Nattel S. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. J Cardiovasc Pharmacol. 2008; 52:293-299.
7. Dobrev D, Voigt N, Wehrens XHT. The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. Cardiovasc Res. 2011;89:734-743.
8. Maleckar MM, Greenstein JL, Giles WR, Trayanova NA. Kcurrent changes account for the rate dependence of the action potential in the human atrial myocyte. Am J Physiol Heart Circ Physiol. 2009;297: H1398-H1410.
9. Nygren A, Fiset C, Firek L, Clark JW, Lindblad DS, Clark RB, Giles WR. Mathematical model of an adult human atrial cell: the role of Kcurrents in repolarization. Circ Res. 1998;82:63-81. (Pubitemid 28074020)
10. Courtemanche M, Ramirez RJ, Nattel S. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol Heart Circ Physiol. 1998;275:H301-H321.
11. Koivumaki JT, Korhonen T, Tavi P. Impact of sarcoplasmic reticulum calcium release on calcium dynamics and action potential morphology in human atrial myocytes: a computational study. PLoS Comput Biol. 2011; 7:e1001067.
12. Grandi E, Pasqualini FS, Bers DM. A novel computational model of the human ventricular action potential and Ca transient. J Mol Cell Cardiol. 2010;48:112-121.
13. Hatem SN, Coulombe A, Balse E. Specificities of atrial electrophysiology: clues to a better understanding of cardiac function and the mechanisms of arrhythmias. J Mol Cell Cardiol. 2010;48:90-95.
14. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet. 2006;15:2185-2191. (Pubitemid 43985509)
15. Dawodu AA, Monti F, Iwashiro K, Schiariti M, Chiavarelli R, Puddu PE. The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol. 1996;54:237-249. (Pubitemid 26226637)
16. Workman AJ, Kane KA, Rankin AC. The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res. 2001;52:226-235. (Pubitemid 33000399)
17. Voigt N, Trafford AW, Ravens U, Dobrev D. Abstract 2630: Cellular and Molecular Determinants of Altered Atrial Ca2f Signaling in Patients With Chronic Atrial Fibrillation. Circulation. 2009;120(18MeetingAbstracts): S667-d-668.
18. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D. L-type Ca2f current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation. 2004;110:2651-2657. (Pubitemid 39453015)
19. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-type Ca2f currents and human atrial fibrillation. Circ Res. 1999;85:428-436. (Pubitemid 29409619)
20. Li GR, Nattel S. Properties of human atrial ICa at physiological temperatures and relevance to action potential. Am J Physiol Heart Circ Physiol. 1997;272:H227-H235.
21. Dobrev D, Graf E, Wettwer E, Himmel HM, Hala O, Doerfel C, Christ T, Schuler S, Ravens U. Molecular basis of downregulation of G-proteincoupled inward rectifying Kcurrent (IK,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced IK,ACh and muscarinic receptor-mediated shortening of action potentials. Circulation. 2001; 104:2551-2557. (Pubitemid 33104792)
22. Boutjdir M, Le Heuzey J, Lavergne T, Chauvaud S, Guize L, Carpentier A, Peronneau P. Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol. 1986;9(6 Pt 2): 1095-1100. (Pubitemid 17206781)
23. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res. 1999;44:121-131. (Pubitemid 29431690)
24. Maier LS, Barckhausen P, Weisser J, Aleksic I, Baryalei M, Pieske B. Ca2f handling in isolated human atrial myocardium. Am J Physiol Heart Circ Physiol. 2000;279:H952-H958.
25. Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C, Vazquez-Jimenez JF, Schoendube F, Hanrath P, Allessie M. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res. 2002;53:192-201. (Pubitemid 34020780)
26. Rocchetti M, Besana A, Mostacciuolo G, Ferrari P, Micheletti R, Zaza A. Diverse toxicity associated with cardiac Na/Kpump inhibition: evaluation of electrophysiological mechanisms. J Pharmacol Exp Ther. 2003; 305:765-771. (Pubitemid 36459198)
27. Hordof AJ, Spotnitz A, Mary-Rabine L, Edie RN, Rosen MR. The cellular electrophysiologic effects of digitalis on human atrial fibers. Circulation. 1978;57:223-229. (Pubitemid 8277773)
28. Wettwer E, Hala O, Christ T, Heubach JF, Dobrev D, Knaut M, Varro A, Ravens U. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation. 2004;110:2299-2306. (Pubitemid 39407330)
29. Schotten U, de Haan S, Verheule S, Harks EG, Frechen D, Bodewig E, Greiser M, Ram R, Maessen J, Kelm M, Allessie M, Van Wagoner DR. Blockade of atrial-specific K-currents increases atrial but not ventricular contractility by enhancing reverse mode Na/Ca2f-exchange. Cardiovasc Res. 2007;73:37-47. (Pubitemid 44937207)
30. Workman AJ. Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2010;381:235-249.
31. Soltis AR, Saucerman JJ. Synergy between CaMKII substrates and betaadrenergic signaling in regulation of cardiac myocyte Ca2f handling. Biophys J. 2010;99:2038-2047.
32. Heijman J, Volders PG, Westra RL, Rudy Y. Local control of betaadrenergic stimulation: effects on ventricular myocyte electrophysiology and Ca2f-transient. J Mol Cell Cardiol. 2011;50:863-871.
33. Caballero R, de la Fuente MG, Gómez R, Barana A, Amorós I, Dolz-Gaitón P, Osuna L, Almendral J, Atienza F, Fernández- Avilés F, Pita A, Rodríguez-Roda J, Pinto Á , Tamargo J, Delpón E. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both. J Am Coll Cardiol. 2010;55:2346-2354.
34. Voigt N, Trausch A, Knaut M, Matschke K, Varro A, Van Wagoner DR, Nattel S, Ravens U, Dobrev D. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:472-480.
35. Narayan SM, Kazi D, Krummen DE, Rappel WJ. Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats. J Am Coll Cardiol. 2008;52:1222-1230.
36. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 1993;73:276-285. (Pubitemid 23212108)
37. Firek L, Giles WR. Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res. 1995;30:31-38.
38. Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S, Jalife J. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J. 2005;88:3806-3821. (Pubitemid 40991096)
39. Pandit SV, Zlochiver S, Filgueiras-Rama D, Mironov S, Yamazaki M, Ennis SR, Noujaim SF, Workman AJ, Berenfeld O, Kalifa J, Jalife J. Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs. Cardiovasc Res. 2011;89:843-851.
40. Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet. 2010;375:1212-1223.
41. Shannon TR, Wang F, Puglisi J, Weber C, Bers DM. A Mathematical treatment of integrated ca dynamics within the ventricular myocyte. Biophys J. 2004;87:3351-3371. (Pubitemid 40468590)
42. Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S, Demolombe S. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol. 2007;582: 675-693. (Pubitemid 47040552)
43. Schram G, Pourrier M, Melnyk P, Nattel S. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res. 2002;90:939-950. (Pubitemid 34633859)
44. Li G-R, Feng J, Yue L, Carrier M, Nattel S. Evidence for two components of delayed rectifier Kcurrent in human ventricular myocytes. Circ Res. 1996;78:689-696. (Pubitemid 26106881)
45. Wang Z, Feng J, Shi H, Pond A, Nerbonne JM, Nattel S. Potential molecular basis of different physiological properties of the transient outward Kcurrent in rabbit and human atrial myocytes. Circ Res. 1999;84:551-561. (Pubitemid 29138592)
46. Severi S, Corsi C, Cerbai E. From in vivo plasma composition to in vitro cardiac electrophysiology and in silico virtual heart: the extracellular calcium enigma. Philosophical Trans R Soc A: Mathematical Physical Eng Sci. 2009;367:2203-2223.
47. Tsujimae K, Suzuki S, Murakami S, Kurachi Y. Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model. Am J Physiol Heart Circ Physiol. 2007;293: H660-H669. (Pubitemid 47105127)
48. Zhang H, Garratt CJ, Zhu J, Holden AV. Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. Cardiovasc Res. 2005;66:493-502. (Pubitemid 40725761)
49. Courtemanche M, Ramirez RJ, Nattel S. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. Cardiovasc Res. 1999;42:477-489. (Pubitemid 29243173)
50. Cherry EM, Hastings HM, Evans SJ. Dynamics of human atrial cell models: restitution, memory, and intracellular calcium dynamics in single cells. Prog Biophys Mol Biol. 2008;98:24-37.
51. Weber CR, Piacentino V III, Ginsburg KS, Houser SR, Bers DM. Na2-Ca2f exchange current and submembrane [Ca2f] during the cardiac action potential. Circ Res. 2002;90:182-189. (Pubitemid 34627087)
52. Hatem SN, Benardeau A, Rucker-Martin C, Marty I, de Chamisso P, Villaz M, Mercadier JJ. Different compartments of sarcoplasmic reticulum participate in the excitation-contraction coupling process in human atrial myocytes. Circ Res. 1997;80:345-353. (Pubitemid 27093348)
53. Lenaerts I, Bito V, Heinzel FR, Driesen RB, Holemans P, D'Hooge J, Heidbuchel H, Sipido KR, Willems R. Ultrastructural and functional remodeling of the coupling between Ca2f influx and sarcoplasmic reticulum Ca2f release in right atrial myocytes from experimental persistent atrial fibrillation. Circ Res. 2009;105:876-885.
54. Jost N, Virag L, Bitay M, Takacs J, Lengyel C, Biliczki P, Nagy Z, Bogats G, Lathrop DA, Papp JG, Varro A. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation. 2005;112:1392-1399. (Pubitemid 41291763)
55. Redpath CJ, Rankin AC, Kane KA, Workman AJ. Anti-adrenergic effects of endothelin on human atrial action potentials are potentially antiarrhythmic. J Mol Cell Cardiol. 2006;40:717-724.
56. Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schondube FA, Hasenfuss G, Belardinelli L, Maier LS. Altered Na2currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol. 2010;55:2330-2342.
57. Shannon TR, Wang F, Bers DM. Regulation of cardiac sarcoplasmic reticulum ca release by luminal [Ca] and altered gating assessed with a mathematical model. Biophys J. 2005;89:4096-4110. (Pubitemid 41725630)
58. Li G-R, Feng J, Wang Z, Fermini B, Nattel S. Adrenergic modulation of ultrarapid delayed rectifier Kcurrent in human atrial myocytes. Circ Res. 1996;78:903-915. (Pubitemid 26131375)
59. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U. Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol. 1996;491(Pt 1):31-50. (Pubitemid 26059547)
60. Wang J, Schwinger RH, Frank K, Müller-Ehmsen J, Martin-Vasallo P, Pressley TA, Xiang A, Erdmann E, McDonough AA. Regional expression of sodium pump subunits isoforms and Na2-Ca2f exchanger in the human heart. J Clin Invest. 1996;98:1650.
61. Neef S, Dybkova N, Sossalla S, Ort KR, Fluschnik N, Neumann K, Seipelt R, Schondube FA, Hasenfuss G, Maier LS. CaMKII-dependent diastolic SR Ca2f leak and elevated diastolic Ca2f levels in right atrial myocardium of patients with atrial fibrillation. Circ Res. 2010;106: 1134-1144.
62. El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D. Molecular determinants of altered Ca2f handling in human chronic atrial fibrillation. Circulation. 2006;114:670-680. (Pubitemid 44252309)
63. Boknik P, Unkel C, Kirchhefer U, Kleideiter U, Klein-Wiele O, Knapp J, Linck B, Luss H, Ulrich Muller F, Schmitz W, Vahlensieck U, Zimmermann N, Jones LR, Neumann J. Regional expression of phospholamban in the human heart. Cardiovasc Res. 1999;43:67-76. (Pubitemid 29322866)
64. Workman AJ, Kane KA, Rankin AC. Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res. 2003;59:593-602. (Pubitemid 38368675)
65. Despa S, Bossuyt J, Han F, Ginsburg KS, Jia L-G, Kutchai H, Tucker AL, Bers DM. Phospholemman-phosphorylation mediates thẽ-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res. 2005;97:252-259. (Pubitemid 41105451)